Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature

Ifosfamide is an alkylating agent used in the treatment of a variety of solid tumours. Ten to 15% of patients treated with ifosfamide develop an encephalopathy. Methylene blue (MB) may be used in the treatment of this encephalopathy. The purpose of this study was to evaluate the neuroprotective effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelgrims, J, Vos, F De, Brande, J Van den, Schrijvers, D, Prové, A, Vermorken, J B
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363270/
https://www.ncbi.nlm.nih.gov/pubmed/10646879
http://dx.doi.org/10.1054/bjoc.1999.0917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363270/
https://www.ncbi.nlm.nih.gov/pubmed/10646879
http://dx.doi.org/10.1054/bjoc.1999.0917

Ejemplares similares